EZZ Life Science targets US expansion

EZZ Life Science Holdings (ASX:EZZ) has set its sights on the lucrative US market after securing regulatory clearance from the United States Food and Drug Administration (FDA) for nine of its products in the food category. This milestone marks a significant leap forward for the genomic life science company as it aims to capitalize on the robust demand for healthcare products in the US.

Read More

BHP’s copper ambitions

If BHP (ASX:BHP) had managed to win control of Anglo American and its 700,000 or so tonnes of annual copper production, would the company’s head of copper in South Australia, Anna Wiley, have stepped up this week and laid down a very upbeat outlook for the company’s position in the red metal?

Read More